Bentham Science Logo

Track Your Manuscript:


Current Pharmaceutical Design

Volume 28, 46 Issues, 2022
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access

Contents

Current Pharmaceutical Design , Volume 26 - Number 4




Review Article

Exploring Dysregulated Signaling Pathways in Cancer

, 26(4): 429 - 445

Sabah Nisar , Sheema Hashem, Muzafar A. Macha , Santosh K. Yadav, Sankavi Muralitharan , Lubna Therachiyil, Geetanjali Sageena, Hamda Al-Naemi, Mohammad Haris and Ajaz A. Bhat*


DOI: 10.2174/1381612826666200115095937





Review Article

Emerging Role of Mitophagy in Inflammatory Diseases: Cellular and Molecular Episodes

, 26(4): 485 - 491

Mohamed Adil A.A., Shabnam Ameenudeen, Ashok Kumar, S. Hemalatha, Neesar Ahmed, Nemat Ali, Abdullah F. AlAsmari, Mohammad Aashique and Mohammad Waseem*


DOI: 10.2174/1381612826666200107144810






Editor-in-Chief

Alessandro Antonelli
(12,288 citations)
Department of Clinical and Experimental Medicine
Laboratory of Primary Human Cells
University of Pisa
Pisa
(Italy)
Biography
View Full Editorial Board

Nobel Laureate on Editorial Board

Andrew V. Schally
(USA)

COPE Compliant

Cope Logo

Journal History

Current Pharmaceutical Design was introduced in 1995. Prof. Alessandro Antonelli serves as the Editor-in-Chief of the journal.

Advertisement

Jan-2022-banMechanisms-of-Metabolic-Disorders-(MMD)

Related Journals

Related eBooks

eBooks Catalog